) and vaccinated, unprotected (n ؍ 11) monkeys by measuring beta-chemokine mRNA levels and protein expression, the frequency of CD8 ؉ T cells expressing beta-chemokines, and the extent of CD8 ؉ -T-cell proliferation. Tissues from uninfected (n ؍ 3) and unvaccinated, SIVmac239-infected (n ؍ 9) monkeys served as controls. Axillary and genital lymph nodes from unvaccinated and vaccinated, unprotected monkeys had significantly higher beta-chemokine mRNA expression levels and increased numbers of beta-chemokine-positive cells than did vaccinated, protected animals. Furthermore, the lymph nodes of vaccinated, unprotected monkeys had significantly higher numbers of beta-chemokine ؉ CD8 ؉ T cells than did vaccinated, protected monkeys. Lymph nodes from vaccinated, unprotected animals also had significantly more CD8 ؉ -T-cell proliferation and marked lymph node hyperplasia than the lymph nodes of vaccinated, protected monkeys. Thus, higher levels of virus replication were associated with increased beta-chemokine secretion and there is no evidence that betachemokines contributed to the SHIV89.6-mediated control of viral replication after intravaginal challenge with SIVmac239.